artemether and lumefantrine cipla dispersible dispersible tablet
cipla limited cipla house, peninsula business park, ganpatrao - artemether and lumefantrine - dispersible tablet - artemether ph. int………20 mg lumefantrine……….120 mg - artemether and lumefantrine
artemether injection solution for injection
crown healthcare crownplex mombasa raod, opp. jkia flyover. p.o. - artemether - solution for injection - artemether 80mg/ml - artemether and lumefantrine
artemether & lumefantrine cipla tablets 80/480 mg
cipla limited cipla house, peninsula business park, ganpatrao - artemether ph.int. and lumefantrine - tablet - each uncoated tablet contains: artemether - artemether and lumefantrine
artemether & lumefantrine cipla tablets
cipla limited cipla house, peninsula business park, ganpatrao - artemether and lumefantrine tablets 20/120mg - tablet - artemether ph int - 20mg, lumefantrine 120mg - antimalarial antiprotozoals: combinations of
amcal petcare insecticidal dusting powder
allied master chemists of australia ltd - ether extracts (derivatives from rotenone) | rotenone - parasiticides - cat | dog | domestic birds | aviary bird | bitch | budgerigar | cage birds | canary | castrate | cat - queen | cat - tom | finch - external parasite | ectoparasitic control
coartem- artemether and lumefantrine tablet
novartis pharmaceuticals corporation - artemether (unii: c7d6t3h22j) (artemether - unii:c7d6t3h22j), lumefantrine (unii: f38r0jr742) (lumefantrine - unii:f38r0jr742) - artemether 20 mg - coartem tablets are indicated for treatment of acute, uncomplicated malaria infections due to plasmodium falciparum (p. falciparum) in patients 2 months of age and older with a bodyweight of 5 kg and above. coartem tablets have been shown to be effective in geographical regions where resistance to chloroquine has been reported [see clinical studies (14.1) ]. limitations of use: - coartem tablets are not approved for patients with severe or complicated p. falciparum malaria. - coartem tablets are not approved for the prevention of malaria. hypersensitivity known hypersensitivity to artemether, lumefantrine, or to any of the excipients of coartem tablets [see adverse reactions (6.2)] . strong cyp3a4 inducers coadministration of strong inducers of cyp3a4 such as rifampin, carbamazepine, phenytoin, and st. john’s wort with coartem tablets can result in decreased concentrations of artemether and/or lumefantrine and loss of antimalarial efficacy [see warnings and precautions (5.3), drug interactions (7.1), and cl
coartem- artemether and lumefantrine tablet
central texas community health centers - artemether (unii: c7d6t3h22j) (artemether - unii:c7d6t3h22j), lumefantrine (unii: f38r0jr742) (lumefantrine - unii:f38r0jr742) - artemether 20 mg - coartem (artemether/lumefantrine) tablets are indicated for treatment of acute, uncomplicated malaria infections due to plasmodium falciparum in patients of 5 kg bodyweight and above. coartem tablets have been shown to be effective in geographical regions where resistance to chloroquine has been reported [see clinical studies (14.1) ]. limitations of use : - coartem tablets are not approved for patients with severe or complicated p. falciparum malaria. - coartem tablets are not approved for the prevention of malaria. hypersensitivity - known hypersensitivity to artemether, lumefantrine, or to any of the excipients of coartem tablets [see adverse reactions (6.3)] . strong cyp3a4 inducers - coadministration of strong inducers of cyp3a4 such as rifampin, carbamazepine, phenytoin, and st. john's wort with coartem tablets can result in decreased concentrations of artemether and/or lumefantrine and loss of antimalarial efficacy [see warnings and precautions (5.3), drug interactions (7.1), and clinical pharmacolo
artemether 20mg and lumefantrine 120mg tablets
ipca laboratories limited 48kandivali industrial estatemumbai 400 067 india. - artemether and lumefantrine - tablet - each tablet contains: artemether ph. int.20 - antimalarial antiprotozoals: plain artemisininand
artemether and lumefantrine dispersible tablets
strides pharma science limited no 36/7, suragajakkanahalli, lndlavadi cross, - artemether and lumefantrine - tablet - each uncoated tablet artemether 20 mg and - antimalarial antiprotozoals: combinations of
artemether and lumefantrine tablets 20/120mg
strides pharma science limited no 36/7, suragajakkanahalli, lndlavadi cross, - artemether and lumefantrine - tablet - each uncoated tablet artemether 20 mg and - antimalarial antiprotozoals: combinations of